Brendan Browne

Emory University

Papers

2

Total Citations

6

H-Index

2

About

Brendan Browne is a urologic surgeon and researcher whose work focuses on advancing surgical techniques and outpatient therapies for urologic conditions, particularly benign prostatic hyperplasia (BPH) and renal-cell carcinoma. His most cited paper, "Advances in Outpatient Therapies and Treatment of Benign Prostatic Hyperplasia" (2024, 4 citations), reviews emerging minimally invasive treatments that reduce hospital stays and improve patient outcomes, reflecting his commitment to translating innovation into clinical practice. Browne also made a notable contribution with "Robot-assisted radical nephrectomy for renal-cell carcinoma during twin pregnancy" (2023, 2 citations), a case report detailing the successful management of a large renal mass in a 23-year-old pregnant woman with twins. This work highlights his expertise in navigating complex, high-stakes scenarios where maternal and fetal health must be balanced—a rare and challenging achievement in urologic oncology. With a growing citation impact, Browne’s research bridges surgical precision and patient-centered care, offering valuable insights for clinicians and trainees alike.

Research Focus

Key Achievements

2
H-Index
2
Papers
6
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Advances in Outpatient Therapies and Treatment of Benign Prostatic Hyperplasia
4 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 2
🏛 Institutions: Emory University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago